Aided by extensive protein mutations, the SARS-CoV-2 Omicron (B. 1.1. 529) variant
overtook the previously dominant Delta variant and rapidly spread around the world. It was …

Since the emergence of COVID 19, the authentic SARS-CoV-2 has evolved into a range of
novel variants that are of more global concern. In late November 2021, the Omicron (lineage …

Previous studies on the Omicron BA. 2 variant suggested that the virological characteristics
of BA. 2 are determined by the mutations in at least two different regions of the viral genome …

The emergence of a heavily mutated SARS-CoV-2 variant (B. 1.1. 529, Omicron) and it's
spread to 6 continents within a week of initial discovery has set off a global public health …

More than two years ago, an unexpectedly high number of patients were reportedly
hospitalized with an atypical pneumonia in Wuhan, Hubei Province, China. Weeks later, the …

In late December of 2019, high-throughput sequencing technologies enabled rapid
identification of SARS-CoV-2 as the etiological agent of COVID-19, and global sequencing …

The first dominant SARS‐CoV‐2 Omicron variant BA. 1 harbours 35 mutations in its Spike
protein from the original SARS‐CoV‐2 variant that emerged late 2019. Soon after its …

Despite many nations' best efforts to contain the so-called COVID-19 pandemic, the
emergence of the SARS-CoV-2 Omicron strain (B. 1.1. 529) has been identified as a serious …

The emergence of the SARS-CoV-2 Omicron variant poses a striking threat to human
society. More than 30 mutations in the Spike protein of the Omicron variant severely …

The rapid accumulation of mutations in the SARS-CoV-2 Omicron variant that enabled its
outbreak raises questions as to whether its proximal origin occurred in humans or another …